Sentiweb - le site du Réseau Sentinelles   INSERM U707Sorbonne Université. Pierre et Marie Curie - Paris 6Santé Publique France
 

    Syndromes Grippaux

    • Surveillance depuis 1984
      Etat : en cours
    • Définition des cas :
      Fièvre supérieure à 39°C, d'apparition brutale, accompagnée de myalgies et de signes respiratoires.

    • Données recueillies pour chaque cas : âge; sexe; statut vaccinal et en cas de vaccination l'injection date-t-elle de moins de 2 semaines; traitement antiviral par oseltamivir prescrit ; Traitement antibiotique prescrit et si oui lequel et pour quelle raison; patient présentant un ou plusieurs facteurs de risque de complications lors d’une infection par un virus de la Grippe; hospitalisation demandée au décours de la consultation et si oui pour quel motif ; Prélèvement naso-pharyngé dans le cadre de la surveillance virologique respiratoire Sentinelles et si oui les 3 premières lettres du nom et du prénom
    En Nouvelle-Aquitaine, la semaine dernière, le taux d’incidence des cas de syndromes grippaux vus en consultations de médecine générale a été estimé à 764 cas pour 100 000 habitants IC 95% [606 ; 922].
    En Nouvelle-Aquitaine, la semaine dernière, le taux d’incidence des cas de syndromes grippaux vus en consultations de médecine générale a été estimé à 808 cas pour 100 000 habitants IC 95% [661 ; 955].
    En Nouvelle-Aquitaine, la semaine dernière, le taux d’incidence des cas de syndromes grippaux vus en consultations de médecine générale a été estimé à 325 cas pour 100 000 habitants IC 95% [245 ; 405].

    Ces blocs d'information sont issues des bulletins utilisant les données disponibles lors de leur publication. Ces données sont soumises à consolidation, une variation peut s'observer dans les 3 semaines suivant leur publication.

    Les données de cette page sont actualisées chaque semaine lors de la publication de notre bulletin le mercredi

    Evolution du taux d'incidence de l'indicateur {{name}} en France métropolitaine

    Téléchargez ou visualisez plus de données rendez-vous sur les pages Base de données > Accès aux données

    Des analyses historiques des données de cet indicateur sont présentées à la page Historique des épidémies

    Les données de cette page sont actualisées chaque semaine lors de la publication de notre bulletin le mercredi

    Publications scientifiques associées à cette maladie
    • Souty C, Masse S, Valette M, Behillil S, Bonmarin I, Pino C, Turbelin C, Capai L, Vilcu AM, Lina B, van der Werf S, Thierry B, Falchi A, Hanslik T. Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care. Clin Microbiol Infect. 2019. In press doi:10.1016/j.cmi.2019.01.014
    • Adlhoch C, Snacken R, Melidou A, Ionescu S, Penttinen P, The European Influenza Surveillance Network. Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. Euro Surveill. 2018. 23(13) PubMed PMC doi:10.2807/1560-7917.ES.2018.23.13.18-00146
    • Ariza M, Guerrisi C, Souty C, Rossignol L, Turbelin C, Hanslik T, Colizza V, Blanchon T. Healthcare-seeking behaviour in case of influenza-like illness in the French general population and factors associated with a GP consultation: an observational prospective study. BJGP Open. 2018. 1(4):bjgpopen17X101253 PubMed PMC doi:10.3399/bjgpopen17X101253
    • Coletti P, Poletto C, Turbelin C, Blanchon T, Colizza V. Shifting patterns of seasonal influenza epidemics. Sci Rep. 2018. 8(1):12786 PubMed PMC doi:10.1038/s41598-018-30949-x
    • Domenech de Cellès M, Arduin H, Varon E, Souty C, Boëlle PY, Lévy-Bruhl D, van der Werf S, Soulary JC, Guillemot D, Watier L, Opatowski L. Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms. Am J Epidemiol. 2018. 187(5):1029-1039 PubMed doi:10.1093/aje/kwx336
    • Guerrisi C, Turbelin C, Souty C, Poletto C, Blanchon T, Hanslik T, Bonmarin I, Levy-Bruhl D, Colizza V. The potential value of crowdsourced surveillance systems in supplementing sentinel influenza networks: the case of France. Euro Surveill. 2018. 23(25) PubMed PMC doi:10.2807/1560-7917.ES.2018.23.25.1700337
    • Hazard A, Bourrion B, Baltazard H, Fournier L, François M. Bénéfices et risques de la prescription d'un traitement homéopathique en prophylaxie antigrippale : exemple de l'influenzinum Exercer. 2018. 148:465-71 Lien PDF
    • Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A, I-MOVE/I-MOVE+ study team. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Influenza Other Respir Viruses. 2018. 12(4):423-437 PubMed PMC doi:10.1111/irv.12520
    • Polyakov P, Souty C, Böelle PY, Breban R. Classification of Spatiotemporal Data for Epidemic Alert Systems: Monitoring Influenza-Like Illness in France. Am J Epidemiol. 2018. PubMed doi:10.1093/aje/kwy254
    • Rondy M, Kissling E, Emborg HD, Gherasim A, Pebody R, Trebbien R, Pozo F, Larrauri A, McMenamin J, Valenciano M, I-Move/I-Move Group. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018. 23(9) PubMed PMC doi:10.2807/1560-7917.ES.2018.23.9.18-00086
    • Souty C, Amoros P, Falchi A, Capai L, Bonmarin I, van der Werf S, Masse S, Turbelin C, Rossignol L, Vilcu AM, Lévy-Bruhl D, Lina B, Minodier L, Dorléans Y, Guerrisi C, Hanslik T, Blanchon T. Influenza epidemics observed in primary care from 1984 to 2017 in France: a decrease of epidemic size over time. Influenza Other Respir Viruses. 2018. PubMed doi:10.1111/irv.12620 PDF
    • Souty C, Jreich R, LE Strat Y, Pelat C, Boëlle PY, Guerrisi C, Masse S, Blanchon T, Hanslik T, Turbelin C. Performances of statistical methods for the detection of seasonal influenza epidemics using a consensus-based gold standard. Epidemiol Infect. 2018. 146(2):168-176 PubMed doi:10.1017/S095026881700276X
    • Valenciano M, Kissling E, Larrauri A, Nunes B, Pitigoi D, O'Donnell J, Reuss A, Horváth JK, Paradowska-Stankiewicz I, Rizzo C, Falchi A, Daviaud I, Brytting M, Meijer A, Kaic B, Gherasim A, Machado A, Ivanciuc A, Domegan L, Schweiger B, Ferenczi A, Korczyńska M, Bella A, Vilcu AM, Mosnier A, Zakikhany K, de Lange M, Kurečić Filipovićović S, Johansen K, Moren A, I-MOVE primary care multicentre case-control team. Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017. Influenza Other Respir Viruses. 2018. PubMed PMC doi:10.1111/irv.12562
    • Vilcu AM, Souty C, Enouf V, Capai L, Turbelin C, Masse S, Behillil S, Valette M, Guerrisi C, Rossignol L, Blanchon T, Lina B, Hanslik T, Falchi A. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method. Clin Microbiol Infect. 2018. 24(4):431.e5-431.e12 PubMed HAL doi:10.1016/j.cmi.2017.09.003
    • Flicoteaux R, Protopopescu C, Tibi A, Blanchon T, Werf SV, Duval X, Mosnier A, Charlois-Ou C, Lina B, Leport C, Chevret S. Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial. BMJ Open. 2017. 7(7):e014546 PubMed PMC doi:10.1136/bmjopen-2016-014546
    • Kissling E, Rondy M, I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017. 22(7) PubMed PMC doi:10.2807/1560-7917.ES.2017.22.7.30464
    • Koppeschaar CE, Colizza V, Guerrisi C, Turbelin C, Duggan J, Edmunds WJ, Kjelsø C, Mexia R, Moreno Y, Meloni S, Paolotti D, Perrotta D, van Straten E, Franco AO. Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe. JMIR Public Health Surveill. 2017. 3(3):e58 PubMed PMC doi:10.2196/publichealth.7429 Lien
    • Minodier L, Masse S, Capai L, Blanchon T, Ceccaldi PE, van der Werf S, Hanslik T, Charrel NR, Falchi A. Risk factors for seasonal influenza virus detection in stools of patients consulting in general practice for acute respiratory infections in France, 2014-2016. Influenza Other Respir Viruses. 2017. PubMed doi:10.1111/irv.12523
    • Minodier L, Masse S, Capai L, Blanchon T, Ceccaldi PE, van der Werf S, Hanslik T, Charrel R, Falchi A. Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine. BMC Infect Dis. 2017. 17(1):729 PubMed PMC doi:10.1186/s12879-017-2823-9
    • Souty C, Vilcu AM, Capai L, van der Werf S, Valette M, Blanchon T, Lina B, Behillil S, Hanslik T, Falchi A. Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France. J Clin Virol. 2017. 95:1-4 PubMed HAL doi:10.1016/j.jcv.2017.08.002
    • Guerrisi C, Turbelin C, Blanchon T, Hanslik T, Bonmarin I, Levy-Bruhl D, Perrotta D, Paolotti D, Smallenburg R, Koppeschaar C, Franco AO, Mexia R, Edmunds WJ, Sile B, Pebody R, van Straten E, Meloni S, Moreno Y, Duggan J, Kjelsø C, Colizza V. Participatory Syndromic Surveillance of Influenza in Europe. J Infect Dis. 2016. 214(suppl 4):S386-S392 PubMed doi:10.1093/infdis/jiw280
    • Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Blanchon T, Bonmarin I, Goffinet F, Ancel PY, Colizza V, Hanslik T, Kernéis S. First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort. BMC Public Health. 2016. 16(1):253 PubMed PMC doi:10.1186/s12889-016-2899-y
    • Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Goffinet F, Colizza V, Hanslik T, Kernéis S, GGNET study group. Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet. Vaccine. 2016. 34(20):2390-6 PubMed doi:10.1016/j.vaccine.2016.03.034
    • Masse S, Minodier L, Heuze G, Blanchon T, Capai L, Falchi A. Influenza-like illness outbreaks in nursing homes in Corsica, France, 2014-2015: epidemiological and molecular characterization. Springerplus. 2016. 5(1):1338 PubMed PMC doi:10.1186/s40064-016-2957-z
    • Souty C, Boëlle PY. Improving incidence estimation in practice-based sentinel surveillance networks using spatial variation in general practitioner density. BMC Med Res Methodol. 2016. 16(1):156 PubMed PMC doi:10.1186/s12874-016-0260-x Lien
    • Spiga R, Batton-Hubert M, Sarazin M. Predicting Fluctuating Rates of Hospitalizations in Relation to Influenza Epidemics and Meteorological Factors. PLoS One. 2016. 11(6):e0157492 PubMed PMC doi:10.1371/journal.pone.0157492
    • Blanchon T, Geffrier F, Turbelin C, Daviaud I, Laouénan C, Duval X, Lambert B, Hanslik T, Mosnier A, Leport C. Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013. Antivir Ther. 2015. 20(7):753-61 PubMed HAL PMC doi:10.3851/IMP2945
    • Boiron K, Sarazin M, Debin M, Raude J, Rossignol L, Guerrisi C, Odinkemelu D, Hanslik T, Colizza V, Blanchon T. Opinion about seasonal influenza vaccination among the general population 3 years after the A(H1N1)pdm2009 influenza pandemic. Vaccine. 2015. 33(48):6849-54 PubMed HAL doi:10.1016/j.vaccine.2015.08.067
    • Minodier L, Charrel RN, Ceccaldi PE, van der Werf S, Blanchon T, Hanslik T, Falchi A. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015. 12(1):215 PubMed PMC doi:10.1186/s12985-015-0448-4
    • Souty C, Blanchon T, Bonmarin I, Lévy-Bruhl D, Behillil S, Enouf V, Valette M, Bouscambert M, Turbelin C, Capai L, Roussel V, Hanslik T, Falchi A. Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France. Hum Vaccin Immunother. 2015. 11(7):1621-5 PubMed HAL PMC doi:10.1080/21645515.2015.1046661
    • Bajardi P, Vespignani A, Funk S, Eames KT, Edmunds WJ, Turbelin C, Debin M, Colizza V, Smallenburg R, Koppeschaar CE, Franco AO, Faustino V, Carnahan A, Rehn M, Paolotti D. Determinants of follow-up participation in the internet-based European influenza surveillance platform influenzanet. J Med Internet Res. 2014. 16(3):e78 PubMed PMC doi:10.2196/jmir.3010
    • Cantarelli P, Debin M, Turbelin C, Poletto C, Blanchon T, Falchi A, Hanslik T, Bonmarin I, Levy-Bruhl D, Micheletti A, Paolotti D, Vespignani A, Edmunds J, Eames K, Smallenburg R, Koppeschaar C, Franco AO, Faustino V, Carnahan A, Rehn M, Colizza V. The representativeness of a European multi-center network for influenza-like-illness participatory surveillance. BMC Public Health. 2014. 14(1):984 PubMed PMC doi:10.1186/1471-2458-14-984
    • Debin M, Colizza V, Blanchon T, Hanslik T, Turbelin C, Falchi A. Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort. Hum Vaccin Immunother. 2014. 10(3):536-43 PubMed PMC
    • Fantoni A, Arena C, Corrias L, Salez N, de Lamballerie X, Amoros JP, Blanchon T, Varesi L, Falchi A. Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France. J Med Virol. 2014. 86(4):585-91 PubMed doi:10.1002/jmv.23745
    • Minodier L, Arena C, Heuze G, Ruello M, Amoros JP, Souty C, Varesi L, Falchi A. Epidemiology and Viral Etiology of the Influenza-Like Illness in Corsica during the 2012-2013 Winter: An Analysis of Several Sentinel Surveillance Systems. PLoS One. 2014. 9(6):e100388 PubMed PMC doi:10.1371/journal.pone.0100388
    • Minodier L, Blanchon T, Souty C, Turbelin C, Leccia F, Varesi L, Falchi A. Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic. Expert Rev Vaccines. 2014. 13(8):1039-48 PubMed doi:10.1586/14760584.2014.930666
    • Paolotti D, Carnahan A, Colizza V, Eames K, Edmunds J, Gomes G, Koppeschaar C, Rehn M, Smallenburg R, Turbelin C, Van Noort S, Vespignani A. Web-based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience. Clin Microbiol Infect. 2014. 20(1):17-21 PubMed doi:10.1111/1469-0691.12477
    • Blanchon T, Mentré F, Charlois-Ou C, Dornic Q, Mosnier A, Bouscambert M, Carrat F, Duval X, Enouf V, Leport C, the Bivir Study Group. Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter. Clin Microbiol Infect. 2013. 19(2):196-203 PubMed doi:10.1111/j.1469-0691.2011.03751.x
    • Debin M, Souty C, Turbelin C, Blanchon T, Boëlle PY, Hanslik T, Hejblum G, Le Strat Y, Quintus F, Falchi A. Determination of French influenza outbreaks periods between 1985 and 2011 through a web-based Delphi method. BMC Med Inform Decis Mak. 2013. 13(1):138 PubMed PMC doi:10.1186/1472-6947-13-138
    • Debin M, Turbelin C, Blanchon T, Bonmarin I, Falchi A, Hanslik T, Levy-Bruhl D, Poletto C, Colizza V. Evaluating the feasibility and participants' representativeness of an online nationwide surveillance system for influenza in france. PLoS One. 2013. 8(9):e73675 PubMed PMC doi:10.1371/journal.pone.0073675
    • Falchi A, Souty C, Grisoni ML, Mosnier A, Hanslik T, Daviaud I, Varesi L, Kerneis S, Carrat F, Blanchon T. Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother. 2013. 9(11):2453-9 PubMed PMC
    • Pelat C, Lasserre A, Xavier A, Turbelin C, Blanchon T, Hanslik T. Hospitalization of influenza-like illness patients recommended by general practitioners in France between 1997 and 2010. Influenza Other Respi Viruses. 2013. 7(1):74-84 PubMed HAL PMC doi:10.1111/j.1750-2659.2012.00356.x
    • Privileggio L, Falchi A, Grisoni ML, Souty C, Turbelin C, Fonteneau L, Hanslik T, Kernéis S. Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners. BMC Public Health. 2013. 13(1):246 PubMed HAL PMC doi:10.1186/1471-2458-13-246
    • Turbelin C, Souty C, Pelat C, Hanslik T, Sarazin M, Blanchon T, Falchi A. Age Distribution of Influenza Like Illness Cases during Post-Pandemic A(H3N2): Comparison with the Twelve Previous Seasons, in France. PLoS One. 2013. 8(6):e65919 PubMed PMC doi:10.1371/journal.pone.0065919
    • Arena C, Amoros JP, Vaillant V, Balay K, Chikhi-Brachet R, Varesi L, Arrighi J, Blanchon T, Carrat F, Hanslik T, Falchi A. Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrhea. Virol J. 2012. 9(1):116 PubMed PMC doi:10.1186/1743-422X-9-116
    • Carrat F, Duval X, Tubach F, Mosnier A, van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F, BIVIR study group. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households. Antivir Ther. 2012. 17(6):1085-90 PubMed doi:10.3851/IMP2128
    • Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, van der Werf S, Lina B. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. Antiviral Res. 2012. 96(2):130-7 PubMed doi:10.1016/j.antiviral.2012.08.002
    • Boëlle PY, Ansart S, Cori A, Valleron AJ. Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respi Viruses. 2011. 5(5):306-16 PubMed PMC doi:10.1111/j.1750-2659.2011.00234.x
    • Falchi A, Amoros JP, Arena C, Arrighi J, Casabianca F, Andreoletti L, Turbelin C, Flahault A, Blanchon T, Hanslik T, Varesi L. Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010. PLoS One. 2011. 6(9):e24471 PubMed PMC doi:10.1371/journal.pone.0024471
    • Falchi A, Turbelin C, Andreoletti L, Arena C, Blanchon T, Bonmarin I, Hanslik T, Leruez-Ville M, De Lamballerie X, Carrat F. Nationwide surveillance of 18 respiratory viruses in patients with influenza-like illnesses: A pilot feasibility study in the French Sentinel Network. J Med Virol. 2011. 83(8):1451-7 PubMed Peer doi:10.1002/jmv.22113
    • Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T. Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France. PLoS One. 2011. 6(5):e19621 PubMed PMC doi:10.1371/journal.pone.0019621
    • Canini L, Andreoletti L, Ferrari P, D'Angelo R, Blanchon T, Lemaitre M, Filleul L, Ferry JP, Desmaizieres M, Smadja S, Valleron AJ, Carrat F. Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One. 2010. 5(11):e13998 PubMed PMC doi:10.1371/journal.pone.0013998
    • Carrat F,Pelat C,Levy-Bruhl D,Bonmarin I,Lapidus N. Planning for the next influenza H1N1 season: a modelling study. BMC Infect Dis. 2010. 10:301 PubMed HAL PMC doi:10.1186/1471-2334-10-301
    • Duval X, van der Werf S, Blanchon T, Mosnier A, Bouscambert-Duchamp M, Tibi A, Enouf V, Charlois-Ou C, Vincent C, Andreoletti L, Tubach F, Lina B, Mentré F, Leport C, BIVIR study group. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010. 7(11):e1000362 PubMed HAL PMC doi:10.1371/journal.pmed.1000362
    • Hanslik T, Boelle PY, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010. PLoS Curr. 2010. 2:RRN1150 PubMed PMC
    • Hanslik T, Kerneis S. Alors docteur, dois-je me faire vacciner contre la grippe A ? [So, doctor, should I take the pandemic flu shot]. Rev Med Interne. 2010. 31(1):1-3 PubMed doi:10.1016/j.revmed.2009.11.005
    • Lemaitre M,Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis. 2010. 10:162 PubMed PMC doi:10.1186/1471-2334-10-162
    • Valleron AJ, Guidet B. Real-time comparative monitoring of the A/H1N1 pandemic in France. Clin Microbiol Infect. 2010. 16(4):393-6 PubMed doi:10.1111/j.1469-0691.2010.03166.x
    • Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, Valleron AJ. Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respi Viruses. 2009. 3(3):99-106 PubMed PMC doi:10.1111/j.1750-2659.2009.00080.x
    • Falchi A, Varesi L, Arena C, Leveque N, Renois F, Blanchon T, Amoros JP, Andreoletti L. Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006-2007 epidemic season in Corsica Island, France. J Clin Virol. 2009. 45(3):265-8 PubMed HAL doi:10.1016/j.jcv.2009.05.004
    • Flahault A, de Lamballerie X, Hanslik T. Symptomatic infections less frequent with H1N1pdm than with seasonal strains PLoS Curr. 2009. 1:RRN1140 PubMed PMC
    • Pelat C,Turbelin C,Bar-Hen A,Flahault A,Valleron AJ. More diseases tracked by using Google Trends. Emerg Infect Dis. 2009. 15(8):1327-8 PubMed PMC doi:10.3201/eid1508.090299
    • Turbelin C,Pelat C,Boëlle PY,Lévy-Bruhl D,Carrat F,Blanchon T,Hanslik T. Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill. 2009. 14(39) PubMed HAL
    • Cauchemez S,Valleron AJ,Boëlle PY,Flahault A,Ferguson NM. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature. 2008. 452(7188):750-4 PubMed doi:10.1038/nature06732
    • Falchi A,Arena C,Andreoletti L,Jacques J,Leveque N,Blanchon T,Lina B,Turbelin C,Dorléans Y,Flahault A,Amoros JP,Spadoni G,Agostini F,Varesi L. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol. 2008. 41(2):148-51 PubMed HAL doi:10.1016/j.jcv.2007.11.003
    • Flahault A. [The epidemiology of influenza pandemics]. Rev Mal Respir. 2008. 25(4):492-6 PubMed
    • Kernéis S,Grais RF,Boëlle PY,Flahault A,Vergu E. Does the effectiveness of control measures depend on the influenza pandemic profile? PLoS One. 2008. 3(1):e1478 PubMed PMC doi:10.1371/journal.pone.0001478
    • Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007. 25(39-40):6852-62 PubMed doi:10.1016/j.vaccine.2007.07.027
    • Colizza V, Barrat A, Barthélemy M, Valleron AJ, Vespignani A. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med. 2007. 4(1):e13 PubMed PMC doi:10.1371/journal.pmed.0040013
    • Denoeud L,Turbelin C,Ansart S,Valleron AJ,Flahault A,Carrat F. Predicting pneumonia and influenza mortality from morbidity data. PLoS One. 2007. 2(5):e464 PubMed PMC doi:10.1371/journal.pone.0000464
    • Cauchemez S, Boëlle PY, Thomas G, Valleron AJ. Estimating in real time the efficacy of measures to control emerging communicable diseases. Am J Epidemiol. 2006. 164(6):591-7 PubMed doi:10.1093/aje/kwj274
    • Flahault A. Global monitoring of influenza: potential contribution of national networks from a French perspective. Expert Rev Anti Infect Ther. 2006. 4(3):387-93 PubMed doi:10.1586/14787210.4.3.387
    • Flahault A, Vergu E, Coudeville L, Grais RF. Strategies for containing a global influenza pandemic. Vaccine. 2006. 24(44-46):6751-5 PubMed doi:10.1016/j.vaccine.2006.05.079
    • Lavenu A, Leruez-Ville M, Chaix ML, Boelle PY, Rogez S, Freymuth F, Hay A, Rouzioux C, Carrat F. Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic. Epidemiol Infect. 2006. 134(3):514-20 PubMed PMC doi:10.1017/S0950268805005686
    • Le Menach A, Vergu E, Grais RF, Smith DL, Flahault A. Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans. Proc Biol Sci. 2006. 273(1600):2467-75 PubMed PMC doi:10.1098/rspb.2006.3609
    • Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine. 2006. 24(44-46):6605-11 PubMed doi:10.1016/j.vaccine.2006.05.063
    • Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005. 437(7056):209-14 PubMed doi:10.1038/nature04017
    • Viboud C, Boëlle PY, Cauchemez S, Lavenu A, Valleron AJ, Flahault A, Carrat F. Risk factors of influenza transmission in households. Br J Gen Pract. 2004. 54(506):684-9 PubMed PMC
    • Viboud C, Boëlle PY, Pakdaman K, Carrat F, Valleron AJ, Flahault A. Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg Infect Dis. 2004. 10(1):32-9 PubMed PMC doi:10.3201/eid1001.020705
    • Viboud C, Pakdaman K, Boëlle PY, Wilson ML, Myers MF, Valleron AJ, Flahault A. Association of influenza epidemics with global climate variability. Eur J Epidemiol. 2004. 19(11):1055-9 PubMed
    • Viboud C, Boëlle PY, Carrat F, Valleron AJ, Flahault A. Prediction of the spread of influenza epidemics by the method of analogues. Am J Epidemiol. 2003. 158(10):996-1006 PubMed
    • Carrat F, Sahler C, Rogez S, Leruez-Ville M, Freymuth F, Le Gales C, Bungener M, Housset B, Nicolas M, Rouzioux C. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med. 2002. 162(16):1842-8 PubMed
    • Flahault A. [Influenza: is it time for mass immunization of healthy infants?]. Rev Epidemiol Sante Publique. 2000. 48(3):311-2 PubMed
    • Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis. 1999. 28(2):283-90 PubMed doi:10.1086/515117
    • Bonabeau E, Toubiana L, Flahault A. The geographical spread of influenza. Proc Biol Sci. 1998. 265(1413):2421-5 PubMed PMC doi:10.1098/rspb.1998.0593
    • Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron AJ. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health. 1998. 52 Suppl 1:32S-38S PubMed
    • Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Field investigation of influenza vaccine effectiveness on morbidity. Vaccine. 1998. 16(9-10):893-8 PubMed
    • Flahault A, Dias-Ferrao V, Chaberty P, Esteves K, Valleron AJ, Lavanchy D. FluNet as a tool for global monitoring of influenza on the Web. JAMA. 1998. 280(15):1330-2 PubMed
    • Toubiana L, Flahault A. A space-time criterion for early detection of epidemics of influenza-like-illness. Eur J Epidemiol. 1998. 14(5):465-70 PubMed
    • Carrat F, Tachet A, Housset B, Valleron AJ, Rouzioux C. Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France. Br J Gen Pract. 1997. 47(417):217-20 PubMed PMC
    • Carrat F. Vaccination against influenza in healthy adults. N Engl J Med. 1996. 334(6):403; author reply 40 PubMed
    • Carrat F, Valleron AJ. Faut-il vacciner tous les adultes contre la grippe? Concours Médical. 1996. 1:8-10
    • Carrat F. [Influenza vaccine among the aged]. Rev Epidemiol Sante Publique. 1995. 43(1):99-101 PubMed
    • Carrat F, Flahault A, Diaz C. Grippe Clinique : Une épidémie exceptionnellement tardive. Bull Epidémiol Hebd. 1995. 17:75 Lien
    • Carrat F, Valleron AJ. [Anti-influenza vaccine. Bibliographic review]. Rev Mal Respir. 1994. 11(3):239-55 PubMed
    • Costagliola D. When is the epidemic warning cut-off point exceeded? Eur J Epidemiol. 1994. 10(4):475-6 PubMed
    • Flahault A, Deguen S, Valleron AJ. A mathematical model for the European spread of influenza. Eur J Epidemiol. 1994. 10(4):471-4 PubMed
    • Hubert B, Watier L, Garnerin P, Richardson S. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis. 1992. 166(3):542-5 PubMed
    • Hubert B, Watier L, Garnerin P, Richardson S. Influence des syndromes grippaux sur l'incidence des infections à méningocoque. Med Mal Infect. 1992. 22(HS):20-2
    • Valleron AJ, Carrat F, Garnerin P. Early detection of epidemic influenza. Lancet. 1992. 339(8784):57-8 PubMed
    • Carrat F, Garnerin P. Epidémie de syndromes grippaux. Bull Epidémiol Hebd. 1991. 50:217 Lien
    • Costagliola D, Flahault A, Galinec D, Garnerin P, Menares J, Valleron AJ. A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health. 1991. 81(1):97-9 PubMed PMC
    • Menares J, Garnerin P, Hubert B, Valleron AJ. Les syndromes grippaux : France 1988-1990. Bull Epidémiol Hebd. 1990. 24:103-4 Lien
    • Menares J, Garnerin P, Valleron AJ. Syndromes grippaux : Surveillance des syndromes grippaux par un réseau téléinformatique national 1984-1989. REH. 1990. 14:103-4 Lien
    • Menares J, Garnerin P, Valleron AJ. Real time surveillance of influenza-like diseases in france through a national computer network. MMWR Morb Mortal Wkly Rep. 1989. 38(49):855-7 PubMed
    • Menares J, Garnerin P, Valleron AJ. Syndromes grippaux : France 1984-1985 à 1988-1989. Bull Epidémiol Hebd. 1989. 38:157-8 Lien
    • Flahault A, Letrait S, Blin P, Hazout S, Ménarés J, Valleron AJ. Modelling the 1985 influenza epidemic in France. Stat Med. 1988. 7(11):1147-55 PubMed
    • Menares J, Brunet A, Garnerin P, Valleron AJ. La surveillance téléinformatique des syndromes grippaux par le réseau national de médecins généralistes sentinelles. Bull Epidémiol Hebd. 1988. 27:106-7 Lien
    • Flahault A. Un nouvel indicateur épidémiologique pour détecter le début d'une épidémie. Bull Epidémiol Hebd. 1986. 47:185 Lien
    Retrouvez toutes les publications scientifiques sur les pagesPublications scientifiques